Skip to content

Clinical trials

Phase 2 Neuroblastoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Phase 2 Country / region: Canada Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20052
20061
20071
20091
20101
20113
20131
20141
20151
20161
20171
20182
20192
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting7
Recruiting3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group9
National Cancer Institute (NCI)6
Giselle Sholler4
New Approaches to Neuroblastoma Therapy Consortium2
Centre de recherche du Centre hospitalier universitaire de Sherbrooke1
Memorial Sloan Kettering Cancer Center1
Molecular Insight Pharmaceuticals, Inc.1
NYU Langone Health1
Pfizer1
Y-mAbs Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma27
Sarcoma9
Central Nervous System Neoplasms7
Medulloblastoma5
Neuroectodermal Tumors, Primitive, Peripheral5
Osteosarcoma5
Hepatoblastoma4
Rhabdomyosarcoma4
Sarcoma, Ewing4
Astrocytoma3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.